Arthritis

Arthritis refers to a group of conditions that affect the joints and the tissues around them, often causing pain, stiffness, swelling and reduced mobility. This category focuses on medications commonly used to relieve joint pain, reduce inflammation and, in some cases, modify underlying disease processes. The range of conditions that bring people to these treatments includes degenerative types such as osteoarthritis, autoimmune inflammatory forms such as rheumatoid arthritis, and crystal-related problems like gout; the medicines in this section address different mechanisms and goals of care.

Many products in the arthritis category are used for short-term relief of acute pain and inflammation, while others are intended for longer-term control or prevention of flares. For example, nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently chosen for symptomatic relief of pain and swelling during a flare or for ongoing symptomatic management. Other agents are used specifically to prevent recurrent gout attacks or to slow immune-driven joint damage in inflammatory arthritis, so the intended use can vary from immediate symptom control to chronic disease management.

The medicines available here can be grouped by how they work. Analgesic and anti-inflammatory options include traditional NSAIDs such as ibuprofen (Motrin) and naproxen (Naprosyn, Anaprox), and older strong NSAIDs like indomethacin (Indocin) or piroxicam (Feldene). COX-2 selective inhibitors such as etoricoxib (Arcoxia) provide an alternative anti-inflammatory approach. Short courses of corticosteroids such as dexamethasone (Dexone) may be used for rapid inflammation control. Drugs for gout include colchicine (Colcrys) for acute attacks and xanthine oxidase inhibitors such as allopurinol (Zyloprim) to reduce uric acid long term. Immune-modifying therapies and immunosuppressants range from conventional agents like cyclosporine (Neoral) to newer targeted treatments such as the JAK inhibitor baricitinib (Olumiant); these are typically used for inflammatory forms of arthritis under medical supervision.

How these medicines are taken and how quickly they act also differs. Many oral NSAIDs start working within hours and are used as needed or on a regular schedule for persistent symptoms. Colchicine and certain NSAIDs are commonly used for the early phase of a gout attack, while uric acid–lowering agents are given daily over months to reduce the frequency of attacks. Disease-modifying and immunosuppressive therapies often require a longer period to show benefit and may be administered orally or by injection depending on the medication and clinical context. Formulations may include tablets, capsules and occasionally parenteral forms for more specialized use.

Safety considerations are an important component of this medication group because different drug classes carry different risks. NSAIDs can be associated with stomach irritation, gastrointestinal bleeding, effects on blood pressure and kidney function; some agents have heart-related safety considerations. Colchicine has a narrow therapeutic window and may produce gastrointestinal effects or, rarely, more serious toxicity at higher doses. Drugs that affect the immune system can increase susceptibility to infections and may require monitoring of blood counts and organ function. Liver and kidney function, potential drug interactions and individual health conditions commonly influence which medicines are appropriate.

When choosing among arthritis medicines, people often weigh factors such as the specific type of arthritis or cause of joint pain, how quickly relief is needed, duration of expected use, side effect profile and convenience of dosing. Other considerations include whether monitoring or specialist involvement is typically part of care, and whether a medication is intended for rapid symptom control or long-term disease management. Product formulation and tolerability, along with information from a healthcare provider or pharmacist, also play a role in selecting an appropriate option for each individual's needs.